Cover
Vol. 11 No. 1 (2021)

Published: June 30, 2021

Pages: 89-98

Research Article

Prevalence of Erectile Dysfunction in Males Post COVID-19 Infection.

Abstract

Many men have reported erectile dysfunction as a consequence of COVID-19 infection. The underlying causes, whether related to hormonal changes or endothelial dysfunction, are not yet fully understood. This study aims to investigate the impact of COVID-19 on male sexual function and fertility, specifically focusing on erectile dysfunction. A cohort of 50 males who had no prior history of erectile dysfunction before contracting COVID-19 was assessed. The study analyzes the progression of these conditions over a 90-day period post-recovery from COVID-19, with a particular emphasis on age-related factors. All males were confirmed infected with COVID-19. Comprehensive medical histories were obtained from all participants, and physical examinations were conducted. The International Index of Erectile Function (IIEF-5) questionnaire was employed to assess erectile dysfunction. Assessments were performed at three separate intervals, 30, 60, and 90 days after their recovery from COVID-19. Participants consistently reported varying degrees of erectile dysfunction, which appeared to improve over time. Notably, the participants who reported erectile dysfunction tended to be older than those who did not, and this age-based distinction was highly significant (p = 0.004). In conclusion, this study highlights the impact of COVID-19 infection on male sexual function, with age and the time post-recovery emerging as significant factors contributing to these effects.

References

  1. Hamming, I., Timens, W., Bulthuis, M.L.C., Lely, A.T., Navis, G.V. and van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, Jun. 2004.203 (2), pp.631-637. Doi: 10.1002/path.1570
  2. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell Apr. 2020; 181:271–280. Doi: 10.1016/j.cell.2020.02.052.
  3. Ibarra, F.P., Mehrad, M., Mauro, M.D., Godoy, M.F.P., Cruz, E.G., Nilforoushzadeh, M.A. and Russo, G.I. Impact of the COVID-19 pandemic on the sexual behavior of the population. The vision of the East and the West. International braz j urol, Jul. 2020. 46, pp.104-112. Doi: 10.1590/S1677-5538.IBJU. 2020.S116.
  4. Jannini, E.A. SM= SM: The interface of systems medicine and sexual medicine for facing non- communicable diseases in a gender-dependent manner. Sexual medicine reviews, Jul. 2017. 5 (3), pp.349-364. Doi: 10.1016/j.sxmr.2017.04.002.
  5. Long, Q. X, Tang X‐J, Shi Q‐L, Li Q, Deng H‐ J, Yuan J, Hu J‐L, Xu W, Zhang Y, Lv F‐J, et 97 al. Clinical and immunological assessment of asymptomatic SARS‐CoV‐2 infections. Nat Med, Aug. 2020, 26, pp.1200-1204. Doi: 10.1038/s41591-020-0965-6.
  6. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. Sep. 2020;173 (5):362- 367. Doi: 10.7326/M20-3012.
  7. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. Jun. 2020;24 (1): 353. Doi: 10.1186/s13054-020-03062-7.
  8. Sansone, A., Mollaioli, D., Ciocca, G., Colonnello, E., Limoncin, E., Balercia, G. and Jannini, E.A., 2021. “Mask up to keep it up”: Preliminary evidence of the association between erectile dysfunction and COVID‐19. Andrology. Jul. 2021, 9 (4):1053-1059. Doi: 10.1111/andr.13003.
  9. Sansone, A., Mollaioli, D., Ciocca, G., Limoncin, E., Colonnello, E., Vena, W. and Jannini, E.A. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. Journal of endocrinological investigation, Feb.2021;44 (2):223-231. Doi: 10.1007/s40618-020-01350-1.
  10. World Health Organization. Coronavirus disease (COVID-19) outbreak Abdullah, et al. http://doi.org/10.28969/IJEIR.v11.i1.r8.21 https://www.who.int.
  11. Saad, H.M., GamalEl Din, S.F., Elbokl, O.M. and Adel, A. Predictive factors of erectile dysfunction in Egyptian individuals after contracting COVID‐19: A prospective case–control study. Andrologia, Feb. 2022. 54 (1), p. e14308.Doi:10.1111/and.14308.
  12. Duman, N., ALzaidi, Z., Aynekin, B., Taskin, D., Demirors, B., Yildirim, A., Sahin, I. O., Bilgili, F., Turanli, E. T., Beccari, T., Bertelli, M., & Dundar, M. (2021). COVID-19 vaccine candidates and vaccine development platforms available worldwide. Journal of pharmaceutical analysis, 11 (6), 675–682. https://doi.org/10.1016/j.jpha.2021.09.004